Skip to main content
. 2017 Apr 1;18(3):319–326. doi: 10.1089/sur.2016.234

Table 2.

Unadjusted Association of Selected Diagnoses and Post-Operative Laboratory Tests during the Index Hospital Encounter with Infection During Re-Admission Stay (Frequency [Column %])

  Re-admission (30 d)  
Diagnosis or Laboratory Value Total (N = 770) No Infection (n = 481) Infection (n = 289) RR (95% CI) pa
Diagnoses during the index admission
 Fluid and electrolyte disorders 104 (13.5) 54 (11.2) 50 (17.3) 1.34 (1.07–1.68) 0.01
 Anemia 157 (20.4) 69 (14.4) 88 (30.5) 1.71 (1.43–2.04) <0.0001
 Chronic kidney disease 195 (25.3) 107 (22.3) 88 (30.5) 1.29 (1.07–1.56) 0.01
 Diabetes 364 (47.3) 208 (43.2) 156 (54.0) 1.31 (1.09–1.57) 0.003
 Lower extremity ulcer 179 (23.3) 92 (19.1) 87 (30.1) 1.42 (1.18–1.72) <0.001
 Thyroid disorders 48 (6.2) 22 (4.6) 26 (9.0) 1.49 (1.13–1.96) 0.01
 End-stage renal disease 91 (11.8) 42 (8.7) 49 (17.0) 1.52 (1.23–1.89) <0.001
 Infections during Index admission
  Any 123 (16.0) 52 (10.8) 71 (24.6) 1.71 (1.42–2.06) <0.0001
  Cellulitis, abscess of leg or foot 64 (8.3) 27 (5.6) 37 (12.8) 1.62 (1.28–2.04) <0.001
  Surgical site 12 (1.6) 7 (1.5) 5 (1.7) 1.11 (0.57–2.19) 0.76
  Urinary tract 21 (2.7) 9 (1.9) 12 (4.2) 1.55 (1.05–2.26) 0.06
  Pneumonia 19 (2.5) 9 (1.9) 10 (3.5) 1.42 (0.92–2.19) 0.16
  Sepsis 9 (1.2) 3 (0.6) 6 (2.1) 1.79 (1.12–2.87) 0.06
  Other 41 (5.3) 15 (3.1) 26 (9.0) 1.76 (1.37–2.26) <0.001
 Other complications
  Hemorrhage/hematoma 30 (3.9) 12 (2.5) 18 (6.2) 1.64 (1.21–2.23) <0.01
  Acute post-hemorrhagic anemia 62 (8.1) 26 (5.4) 36 (12.5) 1.62 (1.29–2.05) <0.001
Post-operative laboratory resultsb
 Hemoglobin (<8 g/dL) 52 (7.9) 14 (3.5) 38 (14.5) 1.98 (1.63–2.40) <0.0001
 Glucose
  Low (<80 mg/dL) 15 (2.3) 9 (2.3) 6 (2.3) 1.00 (0.54–1.88) 0.98
  Optimal (80–180 mg/dL) 548 (83.3) 343 (86.6) 205 (78.2) 0.72 (0.59–0.89) 0.005
  High (>180 mg/dL) 95 (14.4) 44 (11.1) 51 (19.5) 1.43 (1.16–1.78) 0.002
 BUN
  Low (males <8; females <6 mg/dL) 17 (2.6) 12 (3.0) 5 (1.9) 0.73 (0.35–1.54) 0.37
  Normal (males 8–20; females 6–20 mg/dL) 431 (65.5) 279 (70.5) 152 (58.0) 0.73 (0.60–0.88) 0.001
  High (>20 mg/dL) 210 (31.9) 105 (26.5) 105 (40.1) 1.43 (1.19–1.72) 0.0003
 Potassium
  Low (<3.7 mEq/L) 31 (4.7) 25 (6.3) 6 (2.3) 0.47 (0.23–0.98) 0.017
  Normal (3.7–5.2 mEq/L) 591 (89.8) 354 (89.4) 237 (90.5) 1.07 (0.78–1.49) 0.65
  High (3.7–5.2 mEq/L) 36 (5.5) 17 (4.3) 19 (7.3) 1.35 (0.98–1.87) 0.10
 Sodium
  Low (<135 mEq/L) 73 (11.1) 40 (10.1) 33 (12.6) 1.15 (0.88–1.52) 0.31
  Normal (135–145 mEq/L) 580 (88.2) 355 (89.7) 225 (85.9) 0.82 (0.63–1.06) 0.14
  High (>145 mEq/L) 5 (0.8) 1 (0.3) 4 (1.5) 2.02 (1.29–3.17) 0.06
 Platelet count
  Low (<150 103/μL) 73 (11.1) 47 (11.9) 26 (9.9) 0.88 (0.64–1.22) 0.43
  Normal (150–400 103/μL) 539 (81.9) 330 (83.3) 209 (79.8) 0.87 (0.69–1.09) 0.24
  High (>400 103/μL) 46 (7.0) 19 (4.8) 27 (10.3) 1.53 (1.18–1.99) 0.006
 White blood cell count
  Low (< 4.5 103/μL) 6 (0.9) 5 (1.3) 1 (0.4) 0.42 (0.07–2.50) 0.24
  Normal (4.5–11.0 103/μL) 474 (72.0) 299 (75.5) 175 (66.8) 0.78 (0.64–0.95) 0.01
  High (> 11.0 103/μL) 178 (27.1) 92 (23.2) 86 (32.8) 1.32 (1.09–1.60) 0.006
a

Chi-square (t-test for continuous) comparison of having an infection during re-admission stay vs. no infection.

b

The 112 encounters with no post-operative laboratory data are excluded from the laboratory analyses.

CI = confidence interval; RR = relative risk.